Clinical Trials Sponsored by R&D Kanglin Biotech

Total 5 results

Shanghai Public Health Clinical Center
R&D Kanglin Biotech

Unknown

An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients.

HIV Infections | AIDS

China
Institute of Hematology & Blood Diseases Hospital
R&D Kanglin Biotech

Recruiting

Evaluation the Safety and Efficacy of KL003 Cell Injection in the Treatment of Transfusion-dependent β-thalassemia.

Transfusion-dependent Beta-Thalassemia

China
Second Affiliated Hospital, School of Medicine,...
R&D Kanglin Biotech

Not yet recruiting

Safety and Efficacy Study of KL002 in the Treatment of Advanced Primary PD

Parkinson Disease

China
University of East Anglia
PepsiCo Global R&D; Quadram Institute Bioscience

Unknown

Innovation in Food Production Techniques to Improve Bioactive Content (ENRICH)

Bioavailability

United Kingdom
University of East Anglia
Unilever R&D; Quadram Institute Bioscience; Clinical Research and Trials Unit...

Completed

Effects of Anthocyanin on Skin Health and Markers of Cardiovascular Disease Risk

Cardiovascular Disease | Postmenopause | Skin Health

United Kingdom

3

Subscribe